PUBLISHER: The Business Research Company | PRODUCT CODE: 1947073
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947073
Respiratory monitoring devices are used to evaluate the patient's respiratory organs and include patches applied to the body to measure respiration and heart rates. These devices help assess respiratory health, identify abnormalities, and guide treatment in clinical environments.
The primary categories of respiratory monitoring devices include capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and other related equipment. Capnographs, for example, are devices used to monitor the concentration of carbon dioxide in exhaled air, providing both a numerical readout and a graphical waveform tracing. These devices find applications in various medical contexts, including chronic obstructive pulmonary disease (COPD) management, the diagnosis and monitoring of infectious diseases, asthma treatment, and other respiratory health assessments. These devices are used by a range of end-users, including laboratories, hospitals, and individuals for home use.
Tariffs are impacting the respiratory monitoring devices market by increasing costs of imported sensors, semiconductors, wireless modules, and display components used in capnographs, pulse oximeters, and spirometers. Healthcare facilities in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device pricing and delaying technology upgrades. However, they are also encouraging domestic electronics manufacturing, regional assembly of monitoring devices, and innovation in cost-optimized respiratory diagnostics.
The respiratory monitoring devices market research report is one of a series of new reports from The Business Research Company that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory monitoring devices market size has grown strongly in recent years. It will grow from $1.81 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing diagnosis of chronic respiratory conditions, expansion of sleep disorder testing, rising hospital monitoring requirements, availability of compact monitoring devices, growth in preventive healthcare practices.
The respiratory monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected health platforms, expansion of home diagnostic solutions, growing use of ai-driven clinical decision support, increasing focus on personalized respiratory care. Major trends in the forecast period include increasing adoption of wearable respiratory monitoring devices, rising use of continuous remote monitoring systems, growing integration of ai-based data analytics, expansion of home-based respiratory monitoring, enhanced focus on early detection technologies.
The increasing prevalence of pneumonia is expected to drive the growth of the respiratory monitoring devices market. Pneumonia is an infection that impacts one or both lungs, causing the alveoli (air sacs in the lungs) to fill with fluid or pus. This infection triggers inflammation in the lungs, which increases blood vessel permeability and leads to fluid leakage into the alveoli. Respiratory monitoring devices can assist in the early detection and management of pneumonia by offering real-time, continuous monitoring of respiratory rate and other vital signs. For example, in January 2023, the National Center for Biotechnology Information, a US-based government agency, reported that pneumonia affects around 120 million people globally each year, resulting in approximately 1.3 million deaths. Nearly 80% of pneumonia-related deaths in children occur in those under 2 years old in developing countries. As such, the rising prevalence of pneumonia is driving the demand for respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are concentrating on product innovation, including smart inhalers equipped with embedded sensors that track usage patterns and inhalation quality. Smart inhalers are digitally enabled inhalation devices designed to monitor medication use, assess inhalation technique, and deliver real-time reminders or feedback to support improved management of respiratory diseases. For example, in December 2023, Adherium Ltd., a global digital health company, began production and launched its next-generation Hailie Smartinhaler in the U.S. market. The device captures physiological data such as inhalation flow rate in real time and converts a standard pressurized metered-dose inhaler (pMDI) into a connected smart inhaler to support asthma and COPD patients and enable enhanced remote monitoring. This innovation promotes medication adherence and delivers actionable insights to healthcare providers.
In March 2023, VitalConnect, a US-based provider of wearable and remote patient monitoring technologies, acquired Entelechon for $100 million. Through this acquisition, VitalConnect sought to strengthen its position in the digital health and monitoring devices market by expanding its portfolio to include advanced ingestible sensor technologies. Entelechon is a Germany-based company that provides respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic plc, Dragerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.
Asia-Pacific was the largest region in the respiratory monitoring devices market in 2025. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.